Verified peer comparison
Safehold Inc. New Common Stock vs Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Financial Comparison
Safehold Inc. New Common Stock versus Sinovac Biotech, Ltd. - Ordinary Shares (…
Direct answer
Safehold Inc. New Common Stock and Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Safehold Inc. New Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Safehold Inc. New Common Stock Revenue
- 385,552,000 USD
- Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Revenue
- 386,013,000 USD
- Safehold Inc. New Common Stock Operating income
- 307,584,000 USD
- Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Operating income
- -291,322,000 USD